Tag: Novartis

Breaking News: Novartis Temporarily Modifies U.S. Mobile Administration Program for Sandostatin LAR During Pandemic

April 8, 2020

Due to the COVID-19 pandemic and Novartis’ ongoing commitment to support patients, Novartis has temporarily modified the eligibility criteria related to their U.S. mobile administration program (MAP) to allow for use by patients currently receiving…